Top Stock Movers Oct 8, 2026: FLYE, JZ, PCRX
Fly-E Group, Jianzhi Education, Pacira BioSciences, Xiao-I, and Quanome were the biggest stock gainers today — here's what drove each move on October 8, 2026.
FLYE — Fly-E Group, Inc. (+83.5%)
Fly-E Group surged 83.5% to close at $2.33 on volume of roughly 3.65 billion shares — nearly 20× its 20-day average of 182 million shares. That kind of volume relative to normal trading activity (known as relative volume) is a hallmark of speculative frenzy in very small stocks.
No confirmed catalyst was on file for today's move. With a market cap of just $2.1 million, no recent news headlines, and only a pair of management-related 8-K/A filings from mid-September, the catalyst here is unclear — this looks like a momentum- and speculation-driven move. FLYE also appeared in this morning's premarket movers alongside AIXI and DKI (see our Premarket Movers Oct 8, 2026 recap), suggesting the frenzy was building from before the open.
The technical picture is mixed at best. RSI (the Relative Strength Index, a 0–100 momentum gauge — readings above 70 signal overbought conditions) registered 70, meaning the stock was already stretched by the close. The gap open (when a stock opens materially above the prior day's close) was a massive +150.4%, yet FLYE is still 85.5% below its 52-week high, underlining how far it has fallen over time. The conviction score is 69/100, but the short-squeeze score is just 2/100 — with only 2,562 shares short and 0.4 days to cover (the number of days short sellers would need to buy back their positions at average volume), there is almost no short interest here to fuel a squeeze. A free float of 82.2% (the shares actually available for public trading) is relatively large for a name this tiny, which further limits squeeze mechanics.
FLYE carries extreme risk. Micro-cap stocks with no visible catalyst and billion-share volume days frequently reverse sharply once momentum chasers exit.
JZ — Jianzhi Education Technology Group Co Ltd (+78.3%)
Jianzhi Education Technology closed up 78.3% at $0.84, with 230 million shares changing hands — approximately 17.5× its 20-day average of 13.2 million. That is a dramatic spike in activity for a stock with a market cap of just $668,000.
No catalyst was on file for this move, and no recent headlines were found. The catalyst is unclear — this appears to be purely momentum- and speculation-driven. JZ carries a free float of 59.0% (the shares available to the public) and a modest squeeze score of 28/100. Short interest stands at 113,161 shares with 0.0 days to cover, meaning there is virtually no short position large enough to drive a squeeze. The short-volume ratio of 58% — meaning more than half of today's volume involved short sales — is worth watching, as high short-volume in a rising stock can indicate active bearish bets against the move.
Technically, JZ is deeply distressed: its RSI is a neutral 50, its moving average stack is bearish (shorter-term averages sitting below longer-term ones), and it sits 99.1% below its 52-week high. The conviction score is just 24/100, and the grade is D. This is a name that has lost almost everything from its peak and saw a brief, violent spike today on unknown fuel.
This is one of the highest-risk profiles in today's recap. Stocks at sub-$1 prices with no visible catalyst and extreme volume spikes are among the most prone to fast reversals.
AIXI — Xiao-I Corp (+48.1%)
Xiao-I Corp closed up 48.1% to $1.96, on volume of 28 million shares — roughly 2.9× its 20-day average of 9.7 million. The move gapped open +59.5% at the start of the session (a gap occurs when the opening price is far above the prior close), then pulled back somewhat to settle at $1.96 by 4:00 PM ET.
The most prominent context here comes from recent coverage: Timothy Sykes flagged AIXI on October 8 as a name "whipsawing as traders target AI volatility," while Quiver Quantitative noted on October 6 that the jump in AIXI shares appeared driven by "heavy volume and speculative trading." AIXI had also featured in premarket movers on October 6 and appeared in this morning's premarket recap. The pattern is consistent: AIXI is a repeat volatile mover fueled by speculative interest around its AI-adjacent branding, not by a clearly identified fundamental catalyst. Its October 1 6-K filing (a foreign-company report) was tagged neutral.
The squeeze angle deserves attention. AIXI has a free float of just 21.9% — meaning less than a quarter of its shares are freely tradable. Low float is a key amplifier: when demand surges, there are few shares available, so prices can move violently in both directions. Its squeeze score is 52/100, and short volume ran at 59% of today's total — a sign that short sellers were active. Days to cover is 0.0, so the short position is small in absolute terms. The largest disclosed insider/institutional stake is 9.9%. Conviction is 24/100, grade D, and the MA stack is bearish — this is a technically weak stock experiencing speculative bursts. Also see our After-Hours Movers Oct 7 recap where AIXI also featured.
PCRX — Pacira BioSciences, Inc. (+44.5%)
Pacira BioSciences was today's standout from a fundamental standpoint, closing up 44.5% to $36.41 on volume of nearly 15.9 million shares — approximately 12× its 20-day average of 1.3 million. It is the only large-cap name in today's group, with a market cap of $1.0 billion and a Healthcare sector classification.
The catalyst is clear. On October 5, Yahoo Finance reported that Pacira announced an exclusive commercialization agreement with Molteni Farmaceutici to bring its EXPAREL® product to the European Union and United Kingdom. EXPAREL is Pacira's flagship long-acting local anesthetic used in surgical pain management. An exclusive deal to expand into two major international markets represents a meaningful potential revenue opportunity, and the market responded emphatically today.
PCRX's technical profile is the strongest in today's group by a wide margin. RSI hit 85 — deep into overbought territory, though strong catalysts can sustain elevated RSI for extended periods. Critically, the stock closed at a 52-week high, the MA stack is bullish (shorter-term averages above longer-term ones), the conviction score is a perfect 100/100, the grade is A+, and the trend-template score is 8 out of 8 — StockSetups' implementation of the Minervini trend-template, which checks that a stock is in a robust uptrend across multiple timeframes. RS rating of 95 means PCRX has outperformed 95% of the US market over the past year.
The short-squeeze setup here is the most potent in today's recap. PCRX carries 7.3 million shares short, 16.9 days to cover (short sellers would need nearly 17 days at average volume to buy back all short positions — the longer this number, the more trapped shorts may be), and a squeeze score of 89/100. Short volume was 80% of today's total. When a genuine catalyst hits a heavily shorted stock in a strong uptrend, the forced buying from shorts covering can turbocharge a move — that dynamic appears very much at play today.
QNME — Quanome Technologies, Inc. (+42.6%)
Quanome Technologies closed up 42.6% to $0.82 on volume of 94.2 million shares — roughly 2.8× its 20-day average of 34.1 million. The Industrials-sector company has a market cap of $20.1 million.
The likely catalyst is a series of material agreement filings. SEC EDGAR flagged a material agreement 8-K on October 5, and a separate agreement-related 8-K was filed on October 1. While the specific terms of those agreements were not disclosed in the data available, multiple agreement filings in quick succession often signal business development activity that the market can interpret positively — especially in a micro-cap where any new contract can be meaningful relative to the company's size. A shelf registration (S-3/A, which allows a company to sell shares to raise capital) and an annual report (10-K) were also filed in recent weeks. Traders should be aware that S-3 shelf filings can signal future dilution.
Technically, QNME is among the stronger setups in today's group on a relative basis. ADX (the Average Directional Index, a measure of trend strength — readings above 25 suggest a strong trend) stands at 47, indicating a well-established trend, and the stock sits just 3.0% below its 52-week high. Conviction is a perfect 100/100 with an A+ grade, and technical rank is 99 — placing it in the top 1% of the universe by StockSetups' composite technical score. The squeeze score is 30/100; days to cover is 1.3 and the free float is 100%. Short volume of 65% indicates meaningful short-side activity against the move.
The bottom line
Today's five biggest gainers — FLYE, JZ, AIXI, PCRX, and QNME — illustrate just how wide the risk spectrum can be even within a single day's mover list. PCRX had a genuine, identifiable catalyst (an international commercialization deal) and the strongest technical foundation of the group. The others were driven wholly or largely by speculative momentum, with thin or absent fundamental explanations.
Chasing any of these names after a 40%–84% single-day move carries substantial risk. Extended gainers frequently give back a large portion of their gains in the sessions that follow, especially when catalysts are unclear or volume spikes are purely speculative. Short squeezes and low-float momentum moves can reverse as fast as they ignite. The presence of a high squeeze score, as with PCRX, does not guarantee the move continues — it means positioned shorts were squeezed today, not that the pressure remains tomorrow.
Manage your risk carefully, size positions appropriately, and do your own research before acting on any of these names. This recap is educational commentary, not financial advice or a recommendation to buy or sell any security.
StockSetups scans the full ~12,300-stock US universe after every close, detecting chart patterns confirmed by candlestick signals, and sorting actionable setups by conviction score, squeeze score, and smart-money activity. Check back after tomorrow's close — or before the open — for the next mover recap.
Frequently asked questions
Why is FLYE stock up today?
FLYE (Fly-E Group) surged 83.5% on October 8, 2026, on volume roughly 20 times its normal daily average. No confirmed catalyst was identified — the move appears momentum- and speculation-driven in an extremely low market-cap stock.
Why is PCRX stock up today?
Pacira BioSciences (PCRX) jumped 44.5% after announcing an exclusive agreement with Molteni Farmaceutici to commercialize its EXPAREL® pain medication across the European Union and United Kingdom. Heavy short interest (16.9 days to cover) likely amplified the move through a short squeeze.
What is a short squeeze, and why does it matter for today's movers?
A short squeeze happens when a stock rises sharply, forcing traders who bet against it (short sellers) to buy shares to limit losses. That forced buying adds more upward pressure. PCRX had 16.9 days to cover and an 89/100 squeeze score, making it the most prominent squeeze candidate in today's recap.
What does 'low float' mean, and why does AIXI keep appearing in mover recaps?
Float refers to the shares of a stock actually available for public trading. AIXI has a free float of just 21.9%, meaning supply is very limited. When speculative demand spikes in a low-float stock, prices can move violently — which is why AIXI has repeatedly appeared in mover recaps this week.
Are today's big gainers good buy candidates?
Not necessarily. Stocks that have already surged 40%–84% in a single day are extended and carry high reversal risk. This recap is educational only and is not financial advice or a recommendation to buy any security. Always do your own research and manage your risk.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →